These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 32469468)

  • 1. Erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis - diagnosis and treatment.
    Grünwald P; Mockenhaupt M; Panzer R; Emmert S
    J Dtsch Dermatol Ges; 2020 Jun; 18(6):547-553. PubMed ID: 32469468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Erythema multiforme vs. Stevens-Johnson syndrome and toxic epidermal necrolysis: an important diagnostic distinction].
    Rabelink NM; Brakman M; Maartense E; Bril H; Bakker-Wensveen CA; Bavinck JN
    Ned Tijdschr Geneeskd; 2003 Oct; 147(43):2089-94. PubMed ID: 14619195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: a comparative review.
    Yager JA
    Vet Dermatol; 2014 Oct; 25(5):406-e64. PubMed ID: 24990284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment.
    Schwartz RA; McDonough PH; Lee BW
    J Am Acad Dermatol; 2013 Aug; 69(2):187.e1-16; quiz 203-4. PubMed ID: 23866879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythema multiforme, Stevens-Johnson Syndrome, and toxic epidermal necrolysis.
    Rasmussen JE
    Dermatol Nurs; 1995 Feb; 7(1):37-43. PubMed ID: 7756086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme.
    Roujeau JC
    J Dermatol; 1997 Nov; 24(11):726-9. PubMed ID: 9433029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stevens-johnson Syndrome and Toxic Epidermal Necrolysis: An Overview of Diagnosis, Therapy Options and Prognosis of Patients.
    Garg VK; Buttar HS; Bhat SA; Ainur N; Priya T; Kashyap D; Tuli HS
    Recent Adv Inflamm Allergy Drug Discov; 2023; 17(2):110-120. PubMed ID: 37605396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Rzany B; Hering O; Mockenhaupt M; Schröder W; Goerttler E; Ring J; Schöpf E
    Br J Dermatol; 1996 Jul; 135(1):6-11. PubMed ID: 8776350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical factors differentiating erythema multiforme majus from Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN).
    Watanabe R; Watanabe H; Sotozono C; Kokaze A; Iijima M
    Eur J Dermatol; 2011; 21(6):889-94. PubMed ID: 21873140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience.
    Forman R; Koren G; Shear NH
    Drug Saf; 2002; 25(13):965-72. PubMed ID: 12381216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
    Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmoplakin I/II immunohistochemical staining may be a helpful tool in differentiating cutaneous graft versus host disease from the erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis spectrum disorders.
    Irwin T; Yeung CCS; Shinohara MM
    J Cutan Pathol; 2024 Jan; 51(1):76-82. PubMed ID: 37691139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: frozen-section diagnosis.
    Hosaka H; Ohtoshi S; Nakada T; Iijima M
    J Dermatol; 2010 May; 37(5):407-12. PubMed ID: 20536645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of ophthalmologic disease associated with erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis in hospitalized children in the United States.
    Moreau JF; Watson RS; Hartman ME; Linde-Zwirble WT; Ferris LK
    Pediatr Dermatol; 2014; 31(2):163-8. PubMed ID: 23679157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythema Multiforme Versus Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Subtle Difference in Presentation, Major Difference in Management.
    Newkirk RE; Fomin DA; Braden MM
    Mil Med; 2020 Sep; 185(9-10):e1847-e1850. PubMed ID: 32373930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum IL-17 in patients with erythema multiforme or Stevens-Johnson syndrome/toxic epidermal necrolysis drug reaction, and correlation with disease severity.
    Morsy H; Taha EA; Nigm DA; Shahin R; Youssef EMK
    Clin Exp Dermatol; 2017 Dec; 42(8):868-873. PubMed ID: 28940568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients.
    Chan HL; Stern RS; Arndt KA; Langlois J; Jick SS; Jick H; Walker AM
    Arch Dermatol; 1990 Jan; 126(1):43-7. PubMed ID: 2404462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythema multiforme in children versus Stevens-Johnson syndrome].
    Czubkowska I; Barszczak H; Koźniewska D; Wasaznik G
    Wiad Lek; 2000; 53(1-2):43-8. PubMed ID: 10806920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification.
    Roujeau JC
    J Invest Dermatol; 1994 Jun; 102(6):28S-30S. PubMed ID: 8006430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From erythema multiforme to toxic epidermal necrolysis. Same spectrum or different diseases?
    Tomasini C; Derlino F; Quaglino P; Caproni M; Borroni G
    G Ital Dermatol Venereol; 2014 Apr; 149(2):243-61. PubMed ID: 24819646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.